SYN-004 (Ribaxamase), an Orally Administered β-Lactamase for Prevention of Clostridium Difficile Infection in Patients Treated with Intravenous β-Lactam Antibiotics: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study

SSRN Electronic Journal ◽

10.2139/ssrn.3234882 ◽

2018 ◽

Author(s):

John Kokai-Kun ◽

Tracey Roberts ◽

Olivia Coughlin ◽

Chenxiong (Charles) Le ◽

Heidi Whalen ◽

...

Keyword(s):

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13349966.14726746 ◽

2011 ◽

Author(s):

Shafiqul A Sarker

Keyword(s):

Pilot Study ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13349966.14721054 ◽

2011 ◽

Author(s):

Reto Nüesch

Keyword(s):

Pilot Study ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(18)30614-5 ◽

2019 ◽

Vol 19 (3) ◽

pp. 265-274 ◽

Author(s):

Dale N Gerding ◽

Oliver A Cornely ◽

Simon Grill ◽

Hilke Kracker ◽

Anne Claire Marrast ◽

...

Keyword(s):

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkr377 ◽

2011 ◽

Vol 66 (12) ◽

pp. 2850-2855 ◽

Author(s):

K. W. Garey ◽

S. S. Ghantoji ◽

D. N. Shah ◽

M. Habib ◽

V. Arora ◽

...

Keyword(s):

Pilot Study ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718063029.793513708 ◽

2016 ◽

Author(s):

Andrew Dupont

Keyword(s):

Clostridium Difficile ◽

Multicentre Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Older Inpatients ◽

Antibiotic Associated Diarrhoea

Download Full-text

Faculty Opinions recommendation of Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718063029.793481928 ◽

2013 ◽

Author(s):

Eamonn Quigley

Keyword(s):

Clostridium Difficile ◽

Multicentre Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Older Inpatients ◽

Antibiotic Associated Diarrhoea

Download Full-text

Faculty Opinions recommendation of Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718063029.793481824 ◽

2013 ◽

Author(s):

Daniel Diekema

Keyword(s):

Clostridium Difficile ◽

Multicentre Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Older Inpatients ◽

Antibiotic Associated Diarrhoea

Download Full-text

Probiotics for Clostridium difficile infection in adults (PICO): Study protocol for a double-blind, randomized controlled trial

Contemporary Clinical Trials ◽

10.1016/j.cct.2015.07.015 ◽

2015 ◽

Vol 44 ◽

pp. 26-32 ◽

Author(s):

Anna Barker ◽

Megan Duster ◽

Susan Valentine ◽

Laurie Archbald-Pannone ◽

Richard Guerrant ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Study Protocol ◽

Controlled Trial ◽

Double Blind ◽

Randomized Controlled

Download Full-text

Faculty Opinions recommendation of Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718063029.793484322 ◽

2013 ◽

Author(s):

David Alpers

Keyword(s):

Clostridium Difficile ◽

Multicentre Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Older Inpatients ◽

Antibiotic Associated Diarrhoea

Download Full-text

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(17)30235-9 ◽

2017 ◽

Vol 17 (7) ◽

pp. 735-744 ◽

Author(s):

Richard J Vickers ◽

Glenn S Tillotson ◽

Richard Nathan ◽

Sabine Hazan ◽

John Pullman ◽

...

Keyword(s):

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Phase 2 ◽

Efficacy And Safety ◽

Download Full-text